Only a fraction of new HIV infections occur within identifiable stable discordant couples in sub-Saharan Africa

AIDS

Volumn 27, Issue 2, 2013, Pages 251-260

  Chemaitelly, Hiam ^a   Shelton, James D ^b   Hallett, Timothy B ^c   Abu Raddad, Laith J ^a,d,e  

^a Cornell University ^*  (Qatar)

^b UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e USA   (United States)

Author keywords

demographic and health surveys; HIV incidence; mathematical model; sero discordant couples; sub Saharan Africa

Indexed keywords

AFRICA; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MATHEMATICAL MODEL; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEROCONVERSION; VIRUS TRANSMISSION;

AFRICA SOUTH OF THE SAHARA; FEMALE; HETEROSEXUALITY; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; INTERPERSONAL RELATIONS; MALE; MODELS, THEORETICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEXUAL BEHAVIOR; SEXUAL PARTNERS;

EID: 84872408725     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32835ad459     Document Type: Article

References (38)

1. Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010; 362:427-439.
2. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
3. World Health Organization. Guidance on couples HIV testing and counselling including antiretroviral therapy for treatment and prevention in serodiscordant couples. Geneva, Switzerland: Department of HIV/AIDS-World Health Organization; 2012. pp. 15-18.
4. Guthrie BL, De Bruyn G, Farquhar C. HIV-1-discordant couples in Sub-Saharan Africa: explanations and implications for high rates of discordancy. Curr HIV Res 2007; 5:416-429.
5. Lingappa JR, Lambdin B, Bukusi EA, Ngure K, Kavuma L, Inambao M, et al. Regional differencesinprevalenceofHIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial. PLoS One 2008; 3:e1411.
6. Chemaitelly H, Cremin I, Shelton JD, Hallett TB, Abu-Raddad LJ. Distinct HIV discordancy patterns by epidemic size in stable sexual partnerships in sub-Saharan Africa. Sex Transm Infect 2012; 88:51-57.
7. Shelton JD. A tale of two-component generalised HIV epidemics. Lancet 2010; 375:964-966.
8. Dunkle K, Stephenson R, Karita E, Chomba E, Kayitenkore K, Vwalika C, et al. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. The Lancet 2008; 371:2183-2191.
9. Matovu JK. Preventing HIV transmission in married and cohabiting HIV-discordant couples in sub-Saharan Africa through combination prevention. Curr HIV Res 2010; 8:430-440.
10. Gray R, Ssempiija V, Shelton J, Serwadda D, Nalugoda F, Kagaayi J, et al. The contribution of HIV-discordant relationships to new HIV infections in Rakai, Uganda. AIDS 2011; 25:863-865.
11. UNAIDS. HIV estimates with uncertainty bounds 1990-2009. In: Recent reports and data: UNAIDS Report on the Global AIDS Epidemic-2010; 2010. http://www.unaids.org/en/dataanaly-sis/epidemiology/.
12. MEASURE DHS. Demographic and health surveys. In: MEASURE DHS. Calverton: ICF Macro; 2012. http://www.measur edhs.com/data/available-datasets.cfm
13. United Nations Population Division. World Population Prospects: the 2008 Revision Population Database. http://esa.un. org/unpp/index.asp?panel=2. [Accessed August 2011].
14. Rutstein S., Rojas G. Guide to DHS statistics. In. Calverton, Maryland: ORC Macro; 2006. pp. 171. http://www.measur-edhs.com/publications/publication- dhsg1-dhs-questionnaires-and-manuals.cfm
15. MEASURE DHS. Demographic and Health Surveys. In: Frequently asked questions: sampling and weighting: MEASURE DHS; 2011. http://www.measuredhs.com/ faq.cfm
16. UNAIDS. Epidemiological software and tools. http://www.unaids.org/en/ KnowledgeCentre/HIVData/Epidemiology/epi- software2007.asp. 2010. [Accessed September 2011].
17. Stover J, Johnson P, Hallett T, Marston M, Becquet R, Timaeus IM. The Spectrum projection package: improvements in estimating incidence by age and sex, mother-to-child transmission, HIV progression in children and double orphans. Sex Transm Infect 2010; 86 (Suppl 2):ii16-ii21.
18. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191:1403-1409.
19. Hughes JP, Baeten JM, Lingappa JR, Magaret AS, Wald A, de Bruyn G, et al. Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples. J Infect Dis 2012; 205:358-365.
20. Weiss HA, Halperin D, Bailey RC, Hayes RJ, Schmid G, Hankins CA. Male circumcision for HIV prevention: from evidence to action? AIDS 2008; 22:567-574.
21. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005; 2:e298.
22. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. The Lancet 2007; 369:643-656.
23. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. The Lancet 2007; 369:657-666.
24. Eyawo O, de Walque D, Ford N, Gakii G, Lester RT, Mills EJ. HIV status in discordant couples in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10:770-777.
25. Brown MS. Coitus, the proximate determinant of conception: inter-country variance in sub-Saharan Africa. J Biosoc Sci 2000; 32:145-159.
26. Ruzagira E, Wandiembe S, Abaasa A, Bwanika AN, Bahemuka U, Amornkul P, et al. HIV incidence and risk factors for acquisition in HIV discordant couples in Masaka, Uganda: an HIV vaccine preparedness study. PLoS One 2011; 6:e24037.
27. Ndase P, Celum C, Thomas K, Donnell D, Fife KH, Bukusi E, et al. Outside sexual partnerships and risk of HIV acquisition for HIV uninfected partners in African HIV serodiscordant partnerships. J Acquir Immune Defic Syndr 2012; 59:65-71.
28. Mishra V, Barrere B, Hong R, Khan S. Evaluation of bias in HIV seroprevalence estimates from national household surveys. Sex Transm Infect 2008; 84 (Suppl 1):i63-i70.
29. Abu-Raddad LJ, Magaret AS, Celum C, Wald A, Longini IM Jr, Self SG, et al. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS ONE 2008; 3:e2230.
30. Korenromp EL, de Vlass SJ, Nagelkerke NJ, Habbema JD. Estimating the magnitude of STD cofactor effects on HIV transmission: how well can it be done? Sex Transm Dis 2001; 28:613-621.
31. Abu-Raddad LJ, Patnaik P, Kublin JG. Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 2006; 314:1603-1606.
32. Kaul R, Cohen CR, Chege D, Yi TJ, Tharao W, McKinnon LR, et al. Biological factors that may contribute to regional and racial disparities in HIV prevalence. Am J Reprod Immunol 2011; 65:317-324.
33. Novitsky V, Woldegabriel E, Kebaabetswe L, Rossenkhan R, Mlotshwa B, Bonney C, et al. Viral load and CD4R T-cell dynamics in primary HIV-1 subtype C infection. J Acquir Immune Defic Syndr 2009; 50:65-76.
34. Novitsky V, Ndung'u T, Wang R, Bussmann H, Chonco F, Makhema J, et al. Extended high viremics: a substantial fraction of individuals maintain high plasma viral RNA levels after acute HIV-1 subtype C infection. AIDS 2011; 25:1515-1522.
35. Partners PrEP Study Team. Antiretroviral preexposure prophylaxis for HIV-1 prevention among heterosexual African men and women: the Partners PrEP Study. In: 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Rome, Italy: International AIDS Society; 2011.
36. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329:1168-1174.
37. Thigpen MC, Kebaabetswe PM, Smith DK, Segolodi TM, Soud FA, Chillag K, et al. Daily oral antiretroviral use for the prevention of HIV infection in heterosexually active young adults in Botswana: results from the TDF2 study. 6th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention. Rome, Italy: International AIDS Society; 2011.
38. Schwartlander B, Stover J, Hallett T, Atun R, Avila C, Gouws E, et al. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 2011; 377:2031-2041.